In addition, overexpression of miR-196a in MCF7 and MDA-MB-231 cells significantly suppressed SPRED1 protein expression levels, whereas anti-miR-196a inhibitor increased SPRED1 expression, demonstrating that SPRED1 is a direct target of miR-196a in BC cells (Fig. 5c). Here, SPRED1 is linked to breast cancer.